Skip to main content

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
3,019,315
Value
$1.35B
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,019,315$1.35B0.5%−891,471−22.8%ReducedHolders
Q1 20263,910,786$1.77B0.6%−585,696−13.0%ReducedHolders
Q4 20254,496,482$2.04B0.6%−26,104−0.6%ReducedHolders
Q3 20254,522,586$1.77B0.6%+144,266+3.3%AddedHolders
Q2 20254,378,320$1.95B0.6%+424,808+10.7%AddedHolders
Q1 20253,953,512$1.92B0.7%+33,492+0.9%AddedHolders
Q4 20243,920,020$1.58B0.5%−3,452,747−46.8%ReducedHolders
Q3 20247,372,767$3.43B1.2%+151,695+2.1%AddedHolders
Q2 20247,221,072$3.38B1.2%+123,791+1.7%AddedHolders
Q1 20247,097,281$2.97B1.0%+57,543+0.8%AddedHolders
Q4 20237,039,738$2.86B1.1%−486,718−6.5%ReducedHolders
Q3 20237,526,456$2.62B1.1%−8,578−0.1%ReducedHolders
Q2 20237,535,034$2.65B1.1%−838,239−10.0%ReducedHolders
Q1 20238,373,273$2.64B1.1%−696,307−7.7%ReducedHolders
Q4 20229,069,580$2.62B1.2%−75,936−0.8%ReducedHolders
Q3 20229,145,516$2.65B1.3%−154,714−1.7%ReducedHolders
Q2 20229,300,230$2.62B1.2%−1,254,811−11.9%ReducedHolders
Q1 202210,555,041$2.75B1.1%+111,270+1.1%AddedHolders
Q4 202110,443,771$2.29B0.8%+1,374,923+15.2%AddedHolders
Q3 20219,068,848$1.64B0.6%+2,690,416+42.2%AddedHolders
Q2 20216,378,432$1.29B0.5%−1,480,175−18.8%ReducedHolders
Q1 20217,858,607$1.69B0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.